Abstract
Nuclear pore complex in the nuclear envelope plays an important role in controlling the transportation of RNAs, proteins and other macromolecules between the nucleus and cytoplasm. The relationship between abnormal expression of nucleoporins and cardiovascular diseases is unclear. In this study we investigated how myocardial infarction affected the expression and function of nucleoporins in cardiomyocytes. We separately knocked down 27 nucleoporins in rat primary myocardial cells. Among 27 nucleoporins, knockdown of Nup93, Nup210 and Nup214 markedly increased the expression of ANP and BNP, two molecular markers of cardiomyocyte function. We showed that Nup93 was significantly downregulated in hypoxic cardiomyocytes. Knockdown of Nup93 aggravated hypoxia-induced injury and cell death of cardiomyocytes, whereas overexpression of Nup93 led to the opposite effects. RNA-seq and bioinformatics analysis revealed that knockdown of Nup93 did not affect the overall transportation of mRNAs from the nucleus to the cytoplasm, but regulated the transcription of a large number of mRNAs in cardiomyocytes, which are mainly involved in oxidative phosphorylation and ribosome subunits. Most of the down-regulated genes by Nup93 knockdown overlapped with the genes whose promoters could be directly bound by Nup93. Among these genes, we demonstrated that Nup93 knockdown significantly down-regulated the expression of YAP1. Overexpression of YAP1 partially rescued the function of Nup93 knockdown and attenuated the effects of hypoxia on cell injury and cardiomyocyte death. We conclude that down-regulation of Nup93, at least partially, contributes to hypoxia-induced injury and cardiomyocyte death through abnormal interaction with the genome to dynamically regulate the transcription of YAP1 and other genes. These results reveal a new mechanism of Nup93 and might provide new therapeutic targets for the treatment of ischemia-induced heart failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322.
George RM, Firulli AB. Epigenetics and heart development. Front Cell Dev Biol. 2021;9:637996.
Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013;112:707–20.
Kowara M, Borodzicz-Jazdzyk S, Rybak K, Kubik M, Cudnoch-Jedrzejewska A. Therapies targeted at non-coding rnas in prevention and limitation of myocardial infarction and subsequent cardiac remodeling-current experience and perspectives. Int J Mol Sci. 2021;22:5718.
De Luca L. Established and emerging pharmacological therapies for post-myocardial infarction patients with heart failure: a review of the evidence. Cardiovasc Drugs Ther. 2020;34:723–35.
Wang X, Guo Z, Ding Z, Mehta JL. Inflammation, autophagy, and apoptosis after myocardial infarction. J Am Heart Assoc. 2018;7:e008024.
Tsoporis JT, Izhar S, Desjardins JF, Leong-Poi H, Parker TG. Conditional cardiac overexpression of S100A6 attenuates myocyte hypertrophy and apoptosis following myocardial infarction. Curr Pharm Des. 2014;20:1941–9.
Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, et al. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis. 2012;17:410–23.
De Magistris P, Antonin W. The dynamic nature of the nuclear envelope. Curr Biol. 2018;28:R487–97.
Sharakhov IV, Bondarenko SM, Artemov GN, Onufriev AV. The role of chromosome-nuclear envelope attachments in 3D genome organization. Biochemistry. 2018;83:350–8.
Worman HJ, Ostlund C, Wang Y. Diseases of the nuclear envelope. Cold Spring Harb Perspect Biol. 2010;2:a000760.
Paci G, Caria J, Lemke EA. Cargo transport through the nuclear pore complex at a glance. J Cell Sci. 2021;134:jcs247874.
D’Angelo MA, Gomez-Cavazos JS, Mei A, Lackner DH, Hetzer MW. A change in nuclear pore complex composition regulates cell differentiation. Dev Cell. 2012;22:446–58.
Sakuma S, Raices M, Borlido J, Guglielmi V, Zhu EYS, D’Angelo MA. Inhibition of nuclear pore complex formation selectively induces cancer cell death. Cancer Discov. 2021;11:176–93.
Lautier O, Penzo A, Rouviere JO, Chevreux G, Collet L, Loiodice I, et al. Co-translational assembly and localized translation of nucleoporins in nuclear pore complex biogenesis. Mol Cell. 2021;81:2417–27.e5.
Ma J, Kelich JM, Junod SL, Yang W. Super-resolution mapping of scaffold nucleoporins in the nuclear pore complex. J Cell Sci. 2017;130:1299–306.
Patel SS, Belmont BJ, Sante JM, Rexach MF. Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex. Cell. 2007;129:83–96.
Terry LJ, Wente SR. Nuclear mRNA export requires specific FG nucleoporins for translocation through the nuclear pore complex. J Cell Biol. 2007;178:1121–32.
Rodriguez-Berriguete G, Granata G, Puliyadi R, Tiwana G, Prevo R, Wilson RS, et al. Nucleoporin 54 contributes to homologous recombination repair and post-replicative DNA integrity. Nucleic Acids Res. 2018;46:7731–46.
Gozalo A, Duke A, Lan Y, Pascual-Garcia P, Talamas JA, Nguyen SC, et al. Core components of the nuclear pore bind distinct states of chromatin and contribute to polycomb repression. Mol Cell. 2020;77:67–81.e7.
Sumner MC, Brickner J. The nuclear pore complex as a transcription regulator. Cold Spring Harb Perspect Biol. 2022;14:a039438.
Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T, et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell. 2008;135:1017–27.
Xu L, Pan L, Li J, Huang B, Feng J, Li C, et al. Nucleoporin 35 regulates cardiomyocyte pH homeostasis by controlling Na+-H+ exchanger-1 expression. J Mol Cell Biol. 2015;7:476–85.
Nofrini V, Di Giacomo D, Mecucci C. Nucleoporin genes in human diseases. Eur J Hum Genet. 2016;24:1388–95.
Song XW, Li Q, Lin L, Wang XC, Li DF, Wang GK, et al. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes. J Cell Physiol. 2010;225:437–43.
Bersini S, Lytle NK, Schulte R, Huang L, Wahl GM, Hetzer MW. Nup93 regulates breast tumor growth by modulating cell proliferation and actin cytoskeleton remodeling. Life Sci Alliance. 2020;3:e201900623.
Del Viso F, Huang F, Myers J, Chalfant M, Zhang Y, Reza N, et al. Congenital heart disease genetics uncovers context-dependent organization and function of nucleoporins at cilia. Dev Cell. 2016;38:478–92.
Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, et al. Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. Nat Genet. 2016;48:457–65.
Chen X, Xu L. Specific nucleoporin requirement for Smad nuclear translocation. Mol Cell Biol. 2010;30:4022–34.
Monwan W, Kawasaki T, Hasan MZ, Ori D, Kawai T. Identification of nucleoporin 93 (Nup93) that mediates antiviral innate immune responses. Biochem Biophys Res Commun. 2020;521:1077–82.
Yuan X, Scott IC, Wilson MD. Heart enhancers: development and disease control at a distance. Front Genet. 2021;12:642975.
Ibarra A, Benner C, Tyagi S, Cool J, Hetzer MW. Nucleoporin-mediated regulation of cell identity genes. Genes Dev. 2016;30:2253–8.
Funding
This study was supported by the National Natural Science Foundation of China (Nos. 81800310, 82000283, 82070419, 82170275 and 82170233) and General Research Program in Medicine and Health of Zhejiang Province (2020369899).
Author information
Authors and Affiliations
Contributions
JBG, XXZ, and XWS designed the study. LP, XWS, JCS, SHL, CYS, ZKW, and SQH conducted experiments. XWS, LP, and JCS wrote and drafted the manuscript. ZFG, XXZ, and JBG analyzed data. All authors read and approved the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pan, L., Song, Xw., Song, Jc. et al. Downregulation of NUP93 aggravates hypoxia-induced death of cardiomyocytes in vitro through abnormal regulation of gene transcription. Acta Pharmacol Sin 44, 969–983 (2023). https://doi.org/10.1038/s41401-022-01036-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-022-01036-9
Keywords
This article is cited by
-
Mutations in the NUP93, NUP107 and NUP160 genes cause steroid-resistant nephrotic syndrome in Chinese children
Italian Journal of Pediatrics (2024)
-
Abnormal expression of PRKAG2-AS results in dysfunction of cardiomyocytes through regulating PRKAG2 transcription by interacting with PPARG
Clinical Epigenetics (2023)
-
Mechanism of COVID-19-Induced Cardiac Damage from Patient, In Vitro and Animal Studies
Current Heart Failure Reports (2023)